Keyphrases
In Vitro Model
100%
Adenosine
100%
Inosine
100%
Liver Ischemia-reperfusion Injury
100%
Protective Effect
50%
Hypoxia
20%
Liver Ischemia
20%
Oxygen-glucose Deprivation
20%
Receptor-mediated
10%
Clinical Problems
10%
Study Support
10%
Cell Toxicity
10%
Amino
10%
Mode of Action
10%
Cell Viability
10%
Morpholino
10%
Cellular Bioenergetics
10%
Pyrimidine
10%
HepG2
10%
Lactate Dehydrogenase
10%
Diphenyl
10%
Pharmacological Activities
10%
Deoxygenation
10%
Dimethyl
10%
Hydrochloride
10%
Purine Metabolites
10%
Bromide
10%
Ation
10%
Hepatic Ischemia-reperfusion Injury
10%
Tetrazolium
10%
Hypoxic Condition
10%
Adenosine Kinase
10%
Adenosine Receptor Antagonists
10%
Assay Conditions
10%
Thiazolyl
10%
Alternative Energy
10%
Mediated Action
10%
Bromophenyl
10%
Human Hepatocellular Carcinoma
10%
Adenosine Deaminase Inhibitors
10%
ABT-702
10%
Pyrido
10%
Receptor-independent
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cytoprotective Agent
100%
Adenosine
100%
Reperfusion Injury
100%
Inosine
100%
Liver Ischemia
100%
Receptor
20%
Hypoxia
20%
Liver Cell Carcinoma
10%
Adenosine Triphosphate
10%
Purine
10%
Drug Action
10%
Cell Viability
10%
Lactate Dehydrogenase
10%
Tetrazolium
10%
Adenosine Kinase
10%
Biphenyl
10%
Adenosine Deaminase Inhibitor
10%
Adenosine Receptor Blocking Agent
10%
9 (2 Hydroxy 3 Nonyl)adenine
10%
Cytotoxicity
10%
Adenine
10%
Neuroscience
In Vitro
100%
Adenosine
100%
Reperfusion Injury
100%
Inosine
100%
Receptor
20%
Ischemia
20%
Receptor Antagonist
10%
Cell Line
10%
Adenosine Triphosphate
10%
Cytotoxicity
10%
Adenosine Receptor
10%
Cell Viability
10%
Lactate Dehydrogenase
10%
Adenosine Deaminase
10%
Adenine
10%
Purine
10%
9 (2 Hydroxy 3 Nonyl)adenine
10%
Adenosine Kinase
10%
Morpholino
10%